ArticleArthritis and rheumatism2012

Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients.

Justin Gillespie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.